Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 29.04%24.54B | -15.84%19.02B | -10.05%4.86B | -14.14%4.78B | -20.07%4.46B | -18.68%4.92B | -8.05%22.6B | -25.37%5.4B | -4.71%5.57B | 1.08%5.59B |
| Cost of revenue | 42.40%20.23B | -21.78%14.2B | -8.62%3.93B | -17.21%3.66B | -32.54%2.99B | -27.57%3.63B | -11.15%18.16B | -28.59%4.3B | -9.86%4.42B | -0.67%4.44B |
| Gross profit | -10.38%4.32B | 8.40%4.82B | -15.64%928.35M | -2.32%1.12B | 28.02%1.47B | 23.91%1.29B | 7.20%4.44B | -9.40%1.1B | 22.18%1.15B | 8.48%1.15B |
| Operating expense | -0.88%3.55B | -1.43%3.58B | -8.88%873.7M | -5.23%841.23M | -2.83%886.02M | 12.07%978.83M | 8.09%3.63B | 5.13%958.89M | 11.49%887.69M | 7.85%911.81M |
| Operating profit | -37.90%767.2M | 52.47%1.24B | -61.38%54.66M | 7.64%280.31M | 146.15%586.11M | 84.68%314.28M | 3.41%810.22M | -53.22%141.52M | 81.56%260.42M | 10.98%238.11M |
| Net non-operating interest income (expenses) | -121.87%-55.45M | 26.93%-24.99M | 41.28%-4.51M | 18.86%-6.48M | 34.07%-6.24M | 14.46%-7.77M | 1.43%-34.2M | 10.20%-7.68M | 7.75%-7.98M | -10.52%-9.46M |
| Non-operating interest income | 76.71%8.47M | --4.79M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 114.61%63.92M | -12.92%29.78M | 21.13%9.3M | -18.86%6.48M | -34.07%6.24M | -14.46%7.77M | -1.43%34.2M | -10.20%7.68M | -7.75%7.98M | 10.52%9.46M |
| Net investment income | -244.14%-76.84M | -53.56%53.3M | 293.33%15.1M | 92.75%-5.1M | -97.46%2.48M | -57.01%40.83M | 244.95%114.78M | -130.60%-7.81M | -1,158.13%-70.38M | 1,215.10%97.99M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 149.12%26.56M | -80.40%10.66M | -71.23%10.66M | 0 | 1,857.40%54.41M | 396.02%37.06M | ||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -99.91%892K | 1,373.91%995.65M | -6,287.72%-24.69M | 96.02%-1.86M | 82.85%-2.5M | 6,066.58%1.02B | -428.65%-78.16M | -96.13%399K | -422.08%-46.78M | -138.16%-14.6M |
| Less:Other special charges | 99.92%-892K | -2,477.62%-1.12B | 1,229.60%37.6M | -96.02%1.86M | 112.60%2.5M | -6,838.58%-1.16B | 212.37%46.91M | 3,207.69%2.83M | 13,057.89%46.78M | 48.08%-19.87M |
| Less:Write off | --0 | 282.97%119.67M | -300.12%-12.91M | --0 | --0 | --132.58M | -28.09%31.25M | -121.12%-3.23M | --0 | --34.48M |
| Other non-operating income (expenses) | -185.84%-52.1M | -1,532.78%-18.23M | -113.43%-19.6M | 175.13%14.28M | -556.42%-7.5M | -249.03%-5.4M | 225.07%1.27M | 63.42%-9.19M | -60.07%5.19M | -73.25%1.64M |
| Income before tax | -72.90%610.28M | 159.32%2.25B | -79.51%31.61M | 78.15%281.15M | 82.47%572.35M | 463.54%1.37B | 8.31%868.32M | -47.19%154.31M | 15.48%157.82M | 21.65%313.67M |
| Income tax | -69.22%236.32M | 184.26%767.82M | -3.62%51.49M | 401.38%72.93M | 71.47%188.48M | 393.26%454.92M | 164.78%270.11M | 17,673.03%53.42M | -58.89%14.55M | 413.73%109.92M |
| Net income | -74.80%373.96M | 148.06%1.48B | -119.70%-19.88M | 45.33%208.22M | 88.40%383.87M | 506.66%911.71M | -14.51%598.2M | -65.51%100.89M | 41.46%143.27M | -13.83%203.76M |
| Net income continuous operations | -74.80%373.96M | 148.06%1.48B | -119.70%-19.88M | 45.33%208.22M | 88.40%383.87M | 506.66%911.71M | -14.51%598.2M | -65.51%100.89M | 41.46%143.27M | -13.83%203.76M |
| Noncontrolling interests | -75.84%137K | -92.40%567K | 99.75%-8K | -98.92%61K | -97.11%90K | -77.99%424K | -71.27%7.46M | -118.61%-3.24M | 31.48%5.66M | 3.11M |
| Net income attributable to the company | -74.80%373.82M | 151.10%1.48B | -119.08%-19.87M | 51.26%208.16M | 91.28%383.78M | 514.26%911.28M | -12.32%590.74M | -62.15%104.13M | 41.90%137.62M | -13.59%200.64M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -74.80%373.82M | 151.10%1.48B | -119.08%-19.87M | 51.26%208.16M | 91.28%383.78M | 514.26%911.28M | -12.32%590.74M | -62.15%104.13M | 41.90%137.62M | -13.59%200.64M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -74.65%50.36 | 153.29%198.63 | -117.19%-2.41 | 54.74%28.1 | 92.33%50.87 | 516.83%122.07 | -11.00%78.42 | -61.18%14.02 | 41.99%18.16 | -12.33%26.45 |
| Diluted earnings per share | -74.54%50.36 | 153.11%197.78 | -117.29%-2.41 | 54.75%28.01 | 92.19%50.68 | 515.81%121.5 | -11.03%78.14 | -61.28%13.94 | 42.07%18.1 | -12.33%26.37 |
| Dividend per share | 16.67%14 | 20.00%12 | 20.00%12 | 0 | 0 | 0 | 11.11%10 | 11.11%10 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |